Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine (Q57570872)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine	No description defined

Statements

scholarly article

0 references

Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate Dapivirine (English)

0 references

0 references

0 references

José das Neves

object named as

José das Neves

1

0 references

object named as

Bruno Sarmento

7

0 references

author name string

Johan Michiels

2

0 references

Kevin K. Ariën

3

0 references

Guido Vanham

4

0 references

Mansoor Amiji

5

0 references

Maria Fernanda Bahia

6

0 references

publication date

10 November 2011

0 references

Pharmaceutical Research

0 references

29

0 references

6

0 references

1468-1484

0 references

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Microbicides and HIV prevention: lessons from the past, looking to the future

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

First real success for anti-HIV gel: a new start for HIV microbicides?

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Setting the stage: host invasion by HIV.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

HIV sexual transmission and microbicides

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Vaginal drug delivery systems for HIV prevention

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Nanoparticle-based vaginal drug delivery systems for HIV prevention

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

A vaginal fluid simulant

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Measuring HIV neutralization in a luciferase reporter gene assay

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Poly-epsilon-caprolactone microspheres and nanospheres: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Regulated portals of entry into the cell

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Nanoparticle-cell interactions: drug delivery implications

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Correlations between factors determining the pharmacokinetics and antiviral activity of HIV-1 non-nucleoside reverse transcriptase inhibitors of the diaryltriazine and diarylpyrimidine classes of compounds

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Gels as vaginal drug delivery systems.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women

1 reference

https://api.crossref.org/works/10.1007%2FS11095-011-0622-3

21 January 2018

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of surfactants on the molecular aggregation of rhodamine dyes in aqueous solutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22072053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-011-0622-3

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57570872&oldid=1411274337"